{
    "2019-10-31": [
        [
            {
                "time": "2019-10-31",
                "original_text": "Glaxo (GSK) Beats Q3 Earnings Estimates, Raises '19 EPS View",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Q3 Earnings",
                        "Raises",
                        "'19 EPS"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "n/a"
                }
            },
            {
                "time": "2019-10-31",
                "original_text": "Stock Market News For Oct 31, 2019",
                "features": {
                    "keywords": [
                        "Stock Market",
                        "News",
                        "Oct 31"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "n/a",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-10-31",
                "original_text": "Medtronic Introduces Robotics Challenger to Intuitive System",
                "features": {
                    "keywords": [
                        "Medtronic",
                        "Robotics",
                        "Challenger",
                        "Intuitive System"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "n/a"
                }
            },
            {
                "time": "2019-10-31",
                "original_text": "Dicerna ropes in Roche on gene-silencing deal worth up to $1.67B",
                "features": {
                    "keywords": [
                        "Dicerna",
                        "Roche",
                        "gene-silencing",
                        "deal",
                        "$1.67B"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "n/a"
                }
            }
        ]
    ]
}